Novo Nordisk Surge After Wegovy Copycat Abandoned, UK's Starmer Teeters | The Opening Trade 2/9/2026
Why it matters
Novo Nordisk shares surged 8.6% after Hims & Hers Health abandoned its copycat version of Wegovy, while sterling fell to its lowest level against the euro due to the UK's deepening political crisis.
Expected market reaction
Market impact analysis based on bullish sentiment with 85% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 43357
Original source
Novo Nordisk shares surged at the European market Open, reversing some of last week’s plunge, after Hims & Hers Health pulled a copycat version of the new Wegovy weight-loss pill. The Danish pharma giant's stock rose as much as 8.6% in early Copenhagen trading, clocking its biggest gain so far this year. Hims & Hers said it would stop offering the treatment in a post on X Saturday, a day after the US Food and Drug Administration pledged to crack down on copycat weight-loss drugs. Elsewhere, sterling fell against the euro to its lowest level since January 22 as the UK political crisis deepened after Starmer’s chief of staff quit on Sunday. The Opening Trade has everything you need to know as markets open across Europe. With analysis you won't find anywhere else, we break down the biggest stories of the day and speak to top guests who have skin in the game. Hosted by Anna Edwards, Guy Johnson and Tom Mackenzie. (Source: Bloomberg)
Read the full article on Bloomberg
Original article published by Bloomberg on February 9, 2026. Analysis and insights provided by AnalystMarkets AI.
This model on similar stories
Llama 3.1 8B Instant (Groq) · 40.5% correct across 1187 scored calls on indices See the full record